Hester Biosciences Ltd Quarterly Results

Gross Sales

63.22

83.69

82.27

79.26

66.98

Excise Duty

0

0

0

0

0

Net Sales

63.22

83.69

82.27

79.26

66.98

Other Operating Income

0

0

0

0

0

Other Income

8.78

2.8

2.09

4.63

2.2

Total Income

72

86.49

84.35

83.88

69.18

Total Expenditure

58.16

64.53

64.62

63.33

56.83

PBIDT

13.85

21.96

19.74

20.55

12.35

Interest

-3.81

5.89

5.01

6.94

2.19

PBDT

17.66

16.07

14.73

13.61

10.16

Depreciation

4.29

4.2

4.13

3.74

3.75

Minority Interest Before NP

0

0

0

0

0

Tax

1.65

3.38

3.08

3.92

1.74

Deferred Tax

0.31

0.1

0.03

-0.45

0.66

Reported Profit After Tax

11.41

8.39

7.49

6.4

4.02

Minority Interest After NP

-0.25

0.19

1.15

1.45

0.04

Net Profit after Minority Interest

11.66

8.2

6.34

4.95

3.98

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

11.66

8.2

6.34

4.95

3.98

EPS (Unit Curr.)

13.41

9.86

8.8

7.52

4.73

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

8.51

8.51

8.51

8.51

8.51

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

21.9

26.23

23.99

25.92

18.43

PBDTM(%)

27.93

19.2

17.9

17.17

15.16

PATM(%)

18.04

10.02

9.1

8.07

6